{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:56:18Z","timestamp":1790657778064,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010817","name":"Stiftelsen Kronprinsessan Margaretas Arbetsnamnd For Synskadade","doi-asserted-by":"publisher","award":["2022-017"],"award-info":[{"award-number":["2022-017"]}],"id":[{"id":"10.13039\/100010817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018666","name":"Carmen and Bertil Regn\u00e9r's Foundation","doi-asserted-by":"publisher","award":["2022-00071"],"award-info":[{"award-number":["2022-00071"]}],"id":[{"id":"10.13039\/100018666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["20 0798 Fk"],"award-info":[{"award-number":["20 0798 Fk"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","award":["FoUI-981345"],"award-info":[{"award-number":["FoUI-981345"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS-971390"],"award-info":[{"award-number":["SLS-971390"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010810","name":"\u00d6gonfonden","doi-asserted-by":"publisher","award":["2022-05-09"],"award-info":[{"award-number":["2022-05-09"]}],"id":[{"id":"10.13039\/100010810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23447","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T08:55:33Z","timestamp":1702112133000},"page":"e23447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence, risk factors and outcomes of cataract surgery after plaque brachytherapy for posterior uveal melanoma"],"prefix":"10.1016","volume":"10","author":[{"given":"Viktor T.","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-8911","authenticated-orcid":false,"given":"Gustav","family":"St\u00e5lhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e23447_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2022.926034","article-title":"Trends in uveal melanoma presentation and survival during five decades: a nationwide survey of 3898 Swedish patients","volume":"9","author":"Gill","year":"2022","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23447_bib2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.heliyon.2023.e23447_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2022.12.021","article-title":"Robotic CyberKnife radiosurgery for the treatment of choroidal and ciliary body melanoma","volume":"250","author":"Liegl","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23447_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4143\/crt.2016.391","article-title":"Ruthenium-106 brachytherapy with or without additional local therapy shows favorable outcome for variable-sized choroidal melanomas in Korean patients","volume":"50","author":"Cho","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000492391","article-title":"Uveal melanoma in Ireland","volume":"5","author":"Baily","year":"2019","journal-title":"Ocul Oncol Pathol"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23447_bib7","first-page":"5281","article-title":"Brachytherapy of uveal melanomas with ruthenium-106 plaques","volume":"17","author":"Belaid","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23447_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local treatment failure after globe-conserving therapy for choroidal melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23447_bib9","first-page":"280","article-title":"Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis","volume":"11","author":"Frenkel","year":"2009","journal-title":"Isr. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23447_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12886-022-02521-9","article-title":"Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results","volume":"22","author":"Mirshahi","year":"2022","journal-title":"BMC Ophthalmol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23447_bib11","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.prro.2013.08.004","article-title":"Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma","volume":"4","author":"Takiar","year":"2014","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib12","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.prro.2014.09.005","article-title":"A choice of radionuclide: comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma","volume":"5","author":"Takiar","year":"2015","journal-title":"Practical Radiation Oncology"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23447_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bjo.2009.157701","article-title":"Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas","volume":"93","author":"Kaiserman","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23447_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/bjophthalmol-2018-313419","article-title":"Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of >\/=5.5 mm","volume":"104","author":"Fili","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2023.e23447_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12886-015-0150-8","article-title":"Evaluating vision-related quality of life in preoperative age-related cataract patients and analyzing its influencing factors in China: a cross-sectional study","volume":"15","author":"Zhu","year":"2015","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23447_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-0420.2003.0210.x","article-title":"Influence of uveal melanoma therapy on patients' quality of life: a psychological study","volume":"82","author":"Chabert","year":"2004","journal-title":"Acta Ophthalmol. Scand."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2010.02.051","article-title":"Palladium-103 for Choroidal Melanoma Study G. Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy","volume":"80","author":"Finger","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23447_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ophtha.2006.10.039","article-title":"Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27","volume":"114","author":"Collaborative Ocular Melanoma Study","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.heliyon.2023.e23447_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.brachy.2021.05.162","article-title":"Long-term outcomes after enucleation or plaque brachytherapy of choroidal melanomas touching the optic disc","author":"Fili","year":"2021","journal-title":"Brachytherapy"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23447_bib20","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ophtha.2004.03.027","article-title":"Ocular complications after iodine brachytherapy for large uveal melanomas","volume":"111","author":"Puusaari","year":"2004","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1600-0420.2002.800304.x","article-title":"The Swedish national cataract register: a 9-year review","volume":"80","author":"Lundstrom","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23447_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/j.jcrs.0000000000001209","article-title":"Two point four million cataract surgeries: 30 years with the Swedish National Cataract Register, 1992-2021","volume":"49","author":"Bro","year":"2023","journal-title":"J. Cataract Refract. Surg."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23447_bib23","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/s41433-022-02316-8","article-title":"The prognostic implication of visual acuity at the time of uveal melanoma diagnosis","volume":"37","author":"Asplund","year":"2023","journal-title":"Eye (Lond)."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23447_bib24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","article-title":"Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients","volume":"118","author":"Shields","year":"2000","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23447_bib25","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/bmt.2009.359","article-title":"Regression modeling of competing risk using R: an in depth guide for clinicians","volume":"45","author":"Scrucca","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23447_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ophtha.2019.10.007","article-title":"Cataract surgery volumes and complications per surgeon and clinical unit: data from the Swedish national cataract register 2007 to 2016","volume":"127","author":"Zetterberg","year":"2020","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23447_bib28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/M20-6618","article-title":"Risk for acute myocardial infarction after ophthalmologic procedures","volume":"175","author":"Sen","year":"2022","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.adro.2022.101152","article-title":"A prognostic score for the prediction of local treatment failure in plaque brachytherapy of uveal melanoma","volume":"8","author":"Kal Omar","year":"2023","journal-title":"Advances in radiation oncology"},{"key":"10.1016\/j.heliyon.2023.e23447_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.06.077","article-title":"Brachytherapy with 15 versus 20 mm ruthenium-106 plaques without verification of plaque position is associated with local tumor recurrence and death in posterior uveal melanoma","author":"Stalhammar","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.heliyon.2023.e23447_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2023.03.010","article-title":"Genetic status affects disease-specific mortality but not the incidence of local recurrence in patients with uveal melanoma","author":"Bagger","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23447_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","author":"Simpson","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23447_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjo.2004.052159","article-title":"Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy","volume":"89","author":"Finger","year":"2005","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23447_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ICU.0b013e3283386687","article-title":"Classification and treatment of radiation maculopathy","volume":"21","author":"Horgan","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23447_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000497186","article-title":"No gender differences in long-term survival after brachytherapy of 1,541 patients with uveal melanoma","volume":"5","author":"Stalhammar","year":"2019","journal-title":"Ocul Oncol Pathol"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:16:03Z","timestamp":1790655363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023106554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023106554"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23447","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, risk factors and outcomes of cataract surgery after plaque brachytherapy for posterior uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23447"}}